TrialThrombosis and haemostasis2018

Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency.

Manuel Carcao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.